| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lipopeptide binding | 4.87e-08 | 10 | 232 | 5 | GO:0071723 | |
| GeneOntologyMolecularFunction | exogenous lipid antigen binding | 1.52e-05 | 5 | 232 | 3 | GO:0030884 | |
| GeneOntologyMolecularFunction | endogenous lipid antigen binding | 1.52e-05 | 5 | 232 | 3 | GO:0030883 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 3.02e-05 | 6 | 232 | 3 | GO:0030882 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 1.34e-04 | 2 | 232 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 1.34e-04 | 2 | 232 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 1.34e-04 | 2 | 232 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 1.34e-04 | 2 | 232 | 2 | GO:0004354 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 2.31e-06 | 103 | 230 | 9 | GO:0048814 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | 1.35e-05 | 5 | 230 | 3 | GO:0048006 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | RELN HECW1 SARM1 DIP2A PTPRD SEMA4D KALRN SYNE1 GRIN1 LRP4 NEUROG3 | 1.46e-05 | 198 | 230 | 11 | GO:0048813 |
| GeneOntologyBiologicalProcess | dendrite development | RELN HECW1 SARM1 FSTL4 DIP2A SRGAP2C PTPRD PTPRS SEMA4D KALRN SYNE1 GRIN1 LRP4 NEUROG3 | 2.57e-05 | 335 | 230 | 14 | GO:0016358 |
| GeneOntologyBiologicalProcess | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 4.63e-05 | 7 | 230 | 3 | GO:0048007 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of lipid antigen via MHC class Ib | 4.63e-05 | 7 | 230 | 3 | GO:0048003 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 4.85e-05 | 150 | 230 | 9 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | ADCY10 EPOR RELN HECW1 MYO9A TBC1D5 SARM1 FSTL4 SRGAP2C ODF2L PTPRD PTPRS PLD1 CNTN1 SEMA4D KALRN SYNE1 ENC1 GRIN1 TENM3 LRP4 STYXL1 NEUROG3 | 1.05e-04 | 863 | 230 | 23 | GO:0031344 |
| GeneOntologyCellularComponent | transport vesicle membrane | ATR TRPM7 DYSF PTPRS CLTC SEC23A RAB35 FOLR1 ICA1 GRIN1 PHAF1 MYOF SEC23IP KLHL12 | 6.00e-06 | 293 | 234 | 14 | GO:0030658 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 3.53e-05 | 179 | 234 | 10 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 3.53e-05 | 179 | 234 | 10 | GO:0030672 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ATR TRPM7 ABCA13 TBC1D5 TLR6 DYSF TLR8 CFAP65 PTPRS PI4KA CLTC PLD1 SEC23A RAB35 FOLR1 ICA1 LAIR1 LAMP2 GRIN1 ZDHHC17 LDLR PHAF1 CD1A MYOF CD1B CD1D SEC23IP STON2 KLHL12 FCMR | 1.48e-04 | 1307 | 234 | 30 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ATR TRPM7 ABCA13 TBC1D5 TLR6 DYSF TLR8 CFAP65 PTPRS PI4KA CLTC PLD1 SEC23A RAB35 FOLR1 ICA1 LAIR1 LAMP2 GRIN1 ZDHHC17 LDLR PHAF1 CD1A MYOF CD1B CD1D SEC23IP STON2 KLHL12 FCMR | 1.88e-04 | 1325 | 234 | 30 | GO:0012506 |
| GeneOntologyCellularComponent | transport vesicle | ATR TRPM7 SYTL2 DYSF PTPRS CLTC SEC23A RAB35 FOLR1 ICA1 GRIN1 PHAF1 MYOF SEC23IP STON2 KLHL12 | 2.64e-04 | 519 | 234 | 16 | GO:0030133 |
| GeneOntologyCellularComponent | exocytic vesicle | ATR TRPM7 SYTL2 DYSF PTPRS CLTC RAB35 ICA1 GRIN1 PHAF1 MYOF STON2 | 2.77e-04 | 320 | 234 | 12 | GO:0070382 |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 2.92e-04 | 29 | 234 | 4 | GO:0097038 | |
| GeneOntologyCellularComponent | synaptic vesicle | 5.96e-04 | 300 | 234 | 11 | GO:0008021 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 7.37e-04 | 215 | 234 | 9 | GO:0030662 | |
| GeneOntologyCellularComponent | GAIT complex | 7.38e-04 | 4 | 234 | 2 | GO:0097452 | |
| GeneOntologyCellularComponent | secretory vesicle | ATR TRPM7 ABCA13 SYTL2 FSTL4 ACTN2 DYSF F5 CFAP65 PTPRS AGL CCDC62 CLTC PLD1 IL4I1 DNASE1L1 DYNC1H1 GPI RAB35 ICA1 LAIR1 LAMP2 GRIN1 PHAF1 MYOF STON2 FUCA2 | 7.84e-04 | 1246 | 234 | 27 | GO:0099503 |
| GeneOntologyCellularComponent | vesicle coat | 9.25e-04 | 67 | 234 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | synaptic membrane | NCAM2 ACTN2 CNTN6 PTPRD PTPRS CNTN5 CLTC KCNMA1 UTRN CNTN1 SYNE1 GRIN1 ZDHHC17 TENM3 LRP4 SLC16A7 | 9.26e-04 | 583 | 234 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | presynaptic membrane | CNTN6 PTPRD PTPRS CNTN5 CLTC KCNMA1 CNTN1 GRIN1 ZDHHC17 TENM3 | 1.18e-03 | 277 | 234 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | endolysosome membrane | 1.37e-03 | 20 | 234 | 3 | GO:0036020 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 1.59e-03 | 21 | 234 | 3 | GO:0030132 | |
| Domain | ARM-type_fold | GBF1 ATR STAG1 SARM1 DOCK5 PIK3C2A RPTOR PI4KA CLTC DOCK9 RTTN USP24 PPP4R3A RIC8B ARVCF FHOD1 INTS4 STAG2 | 1.88e-07 | 339 | 227 | 18 | IPR016024 |
| Domain | Spectrin | 2.56e-07 | 23 | 227 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 1.13e-06 | 29 | 227 | 6 | IPR002017 | |
| Domain | SPEC | 2.10e-06 | 32 | 227 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.10e-06 | 32 | 227 | 6 | IPR018159 | |
| Domain | DysFC | 7.02e-06 | 4 | 227 | 3 | SM00694 | |
| Domain | DysFN | 7.02e-06 | 4 | 227 | 3 | SM00693 | |
| Domain | Peroxin/Ferlin | 7.02e-06 | 4 | 227 | 3 | IPR006614 | |
| Domain | MHC_I_3 | 3.45e-05 | 6 | 227 | 3 | PF16497 | |
| Domain | - | EPOR FSTL4 NCAM2 CNTN6 PTPRD PTPRS CNTN5 CD101 CAMTA1 CNTN1 MPZ SEMA4D KALRN LAIR1 CD1A TGM3 CD1B CD1D IL2RG CD96 FCMR | 6.27e-05 | 663 | 227 | 21 | 2.60.40.10 |
| Domain | FN3 | EPOR KIAA0319L NCAM2 CNTN6 PTPRD PTPRS CNTN5 CNTN1 KALRN IL2RG | 9.15e-05 | 185 | 227 | 10 | SM00060 |
| Domain | TIR | 1.08e-04 | 21 | 227 | 4 | SM00255 | |
| Domain | IG_LIKE | FSTL4 NCAM2 CNTN6 PTPRD PTPRS CNTN5 CD101 CNTN1 MPZ SEMA4D KALRN LAIR1 CD1A CD1B CD1D CD96 FCMR | 1.12e-04 | 491 | 227 | 17 | PS50835 |
| Domain | ELFV_dehydrog_N | 1.47e-04 | 2 | 227 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 1.47e-04 | 2 | 227 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 1.47e-04 | 2 | 227 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 1.47e-04 | 2 | 227 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 1.47e-04 | 2 | 227 | 2 | PF00208 | |
| Domain | NAD_bind_Glu_DH | 1.47e-04 | 2 | 227 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 1.47e-04 | 2 | 227 | 2 | PS00074 | |
| Domain | ELFV_dehydrog | 1.47e-04 | 2 | 227 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 1.47e-04 | 2 | 227 | 2 | IPR033524 | |
| Domain | Ig-like_dom | FSTL4 NCAM2 CNTN6 PTPRD PTPRS CNTN5 CD101 CNTN1 MPZ SEMA4D KALRN LAIR1 CD1A CD1B CD1D CD96 FCMR | 1.49e-04 | 503 | 227 | 17 | IPR007110 |
| Domain | Ig-like_fold | EPOR FSTL4 NCAM2 CNTN6 PTPRD PTPRS CNTN5 CD101 CAMTA1 CNTN1 MPZ SEMA4D KALRN LAIR1 CD1A TGM3 CD1B CD1D IL2RG CD96 FCMR | 1.51e-04 | 706 | 227 | 21 | IPR013783 |
| Domain | - | 1.57e-04 | 23 | 227 | 4 | 3.40.50.10140 | |
| Domain | ACTININ_2 | 1.57e-04 | 23 | 227 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.57e-04 | 23 | 227 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.57e-04 | 23 | 227 | 4 | IPR001589 | |
| Domain | fn3 | 1.67e-04 | 162 | 227 | 9 | PF00041 | |
| Domain | TIR | 1.87e-04 | 24 | 227 | 4 | PS50104 | |
| Domain | A2M | 2.00e-04 | 10 | 227 | 3 | PF00207 | |
| Domain | A2M_N_2 | 2.00e-04 | 10 | 227 | 3 | IPR011625 | |
| Domain | A2M_comp | 2.00e-04 | 10 | 227 | 3 | IPR011626 | |
| Domain | A2M_recep | 2.00e-04 | 10 | 227 | 3 | PF07677 | |
| Domain | A2M_comp | 2.00e-04 | 10 | 227 | 3 | PF07678 | |
| Domain | A2M_N | 2.00e-04 | 10 | 227 | 3 | PF01835 | |
| Domain | A2M_N | 2.00e-04 | 10 | 227 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.00e-04 | 10 | 227 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.00e-04 | 10 | 227 | 3 | PS00477 | |
| Domain | A2M_N_2 | 2.00e-04 | 10 | 227 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 2.00e-04 | 10 | 227 | 3 | IPR001599 | |
| Domain | TIR_dom | 2.20e-04 | 25 | 227 | 4 | IPR000157 | |
| Domain | FN3_dom | EPOR KIAA0319L NCAM2 CNTN6 PTPRD PTPRS CNTN5 CNTN1 KALRN IL2RG | 2.48e-04 | 209 | 227 | 10 | IPR003961 |
| Domain | WW | 2.84e-04 | 48 | 227 | 5 | SM00456 | |
| Domain | WW_DOMAIN_1 | 3.78e-04 | 51 | 227 | 5 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.78e-04 | 51 | 227 | 5 | PS50020 | |
| Domain | WW_dom | 4.14e-04 | 52 | 227 | 5 | IPR001202 | |
| Domain | FerA | 4.38e-04 | 3 | 227 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 4.38e-04 | 3 | 227 | 2 | IPR012560 | |
| Domain | FerA | 4.38e-04 | 3 | 227 | 2 | PF08165 | |
| Domain | ARM-like | ATR STAG1 SARM1 RPTOR RTTN PPP4R3A RIC8B ARVCF FHOD1 INTS4 STAG2 | 4.86e-04 | 270 | 227 | 11 | IPR011989 |
| Domain | Ig_I-set | 5.42e-04 | 190 | 227 | 9 | IPR013098 | |
| Domain | I-set | 5.42e-04 | 190 | 227 | 9 | PF07679 | |
| Domain | Ldl_recept_b | 5.84e-04 | 14 | 227 | 3 | PF00058 | |
| Domain | LDLRB | 5.84e-04 | 14 | 227 | 3 | PS51120 | |
| Domain | IG | FSTL4 NCAM2 CNTN6 PTPRD PTPRS CNTN5 CD101 CNTN1 MPZ SEMA4D KALRN LAIR1 CD96 FCMR | 6.69e-04 | 421 | 227 | 14 | SM00409 |
| Domain | Ig_sub | FSTL4 NCAM2 CNTN6 PTPRD PTPRS CNTN5 CD101 CNTN1 MPZ SEMA4D KALRN LAIR1 CD96 FCMR | 6.69e-04 | 421 | 227 | 14 | IPR003599 |
| Domain | PI3/4_kinase_CS | 7.24e-04 | 15 | 227 | 3 | IPR018936 | |
| Domain | LY | 7.24e-04 | 15 | 227 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.24e-04 | 15 | 227 | 3 | IPR000033 | |
| Domain | FN3 | 7.55e-04 | 199 | 227 | 9 | PS50853 | |
| Domain | PLDc | 8.68e-04 | 4 | 227 | 2 | PF00614 | |
| Domain | SCD | 8.68e-04 | 4 | 227 | 2 | PS51425 | |
| Domain | SCD | 8.68e-04 | 4 | 227 | 2 | IPR020839 | |
| Domain | STAG | 8.68e-04 | 4 | 227 | 2 | PF08514 | |
| Domain | STAG | 8.68e-04 | 4 | 227 | 2 | IPR013721 | |
| Domain | - | 8.83e-04 | 16 | 227 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 8.83e-04 | 16 | 227 | 3 | SM00146 | |
| Domain | - | 1.25e-03 | 39 | 227 | 4 | 2.120.10.30 | |
| Domain | PI3_PI4_kinase | 1.26e-03 | 18 | 227 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.26e-03 | 18 | 227 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.26e-03 | 18 | 227 | 3 | PS00916 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.26e-03 | 18 | 227 | 3 | IPR008930 | |
| Domain | PI3/4_kinase_cat_dom | 1.26e-03 | 18 | 227 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.26e-03 | 18 | 227 | 3 | PS50290 | |
| Domain | FerI | 1.44e-03 | 5 | 227 | 2 | SM01202 | |
| Domain | FerB | 1.44e-03 | 5 | 227 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.44e-03 | 5 | 227 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.44e-03 | 5 | 227 | 2 | PF16165 | |
| Domain | Ferlin_C | 1.44e-03 | 5 | 227 | 2 | IPR032362 | |
| Domain | FerIin_dom | 1.44e-03 | 5 | 227 | 2 | IPR012968 | |
| Domain | FerI | 1.44e-03 | 5 | 227 | 2 | PF08151 | |
| Domain | FerB | 1.44e-03 | 5 | 227 | 2 | PF08150 | |
| Domain | Toll-like_receptor | 1.44e-03 | 5 | 227 | 2 | IPR017241 | |
| Domain | CH | 1.62e-03 | 70 | 227 | 5 | PF00307 | |
| Domain | Kelch_1 | 1.62e-03 | 70 | 227 | 5 | PF01344 | |
| Domain | Kelch_1 | 1.62e-03 | 70 | 227 | 5 | IPR006652 | |
| Domain | - | 1.72e-03 | 71 | 227 | 5 | 1.10.418.10 | |
| Domain | BTB-kelch_protein | 1.81e-03 | 43 | 227 | 4 | IPR017096 | |
| Domain | CH | 1.95e-03 | 73 | 227 | 5 | PS50021 | |
| Domain | PLDc | 2.14e-03 | 6 | 227 | 2 | SM00155 | |
| Domain | EFhand_Ca_insen | 2.14e-03 | 6 | 227 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 2.14e-03 | 6 | 227 | 2 | IPR014837 | |
| Domain | CH-domain | 2.20e-03 | 75 | 227 | 5 | IPR001715 | |
| Domain | - | 2.24e-03 | 148 | 227 | 7 | 2.60.40.150 | |
| Domain | - | 2.30e-03 | 22 | 227 | 3 | 2.130.10.30 | |
| Domain | TIR | 2.30e-03 | 22 | 227 | 3 | PF01582 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.32e-03 | 46 | 227 | 4 | IPR011042 | |
| Domain | IGc2 | 2.39e-03 | 235 | 227 | 9 | SM00408 | |
| Domain | Ig_sub2 | 2.39e-03 | 235 | 227 | 9 | IPR003598 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 2.32e-05 | 96 | 173 | 8 | M26973 | |
| Pubmed | MAGI1 HECW1 TBL1Y TBC1D5 CHD4 NEK9 DST PTPRD KLHL7 PTPRS RPTOR PI4KA SVIL CLTC KCNMA1 DYNC1H1 SEC23A CNTN1 TCOF1 KALRN SYNE1 DLGAP4 HECTD4 CHD8 GRIN1 TBL1XR1 ARVCF SEC23IP STON2 | 1.90e-11 | 963 | 234 | 29 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MIS18BP1 GAPDH MYO9A CHD4 SSBP1 URB2 SSR4 TRIP13 NEK9 DST PIK3C2A RPTOR PI4KA A2ML1 CLTC DDX60L ASCC3 UTRN IMMT DYNC1H1 SEC23A GPI ARHGAP23 POLRMT CHD8 COLGALT1 PAICS TGM3 ARVCF CTR9 FHOD1 RPL13A ZMYM3 | 1.76e-10 | 1353 | 234 | 33 | 29467282 |
| Pubmed | GAPDH MYO9A SPTA1 NCAM2 ACTN2 DIP2A DST PTPRS RPTOR PI4KA SVIL GLUD1 GLUD2 CLTC MCAT UTRN SLC25A23 IMMT DYNC1H1 SEC23A CNTN1 GPI ARHGAP23 KALRN SYNE1 DLGAP4 GRIN1 SACM1L ARHGAP5 MAPRE3 ARVCF STON2 TRAPPC10 RPL13A | 1.80e-10 | 1431 | 234 | 34 | 37142655 | |
| Pubmed | DCHS2 RELN STAG1 TRPM7 KIAA0319L NCAM2 CHD4 CHUK DIP2A ODF2L DST PTPRD KLHL7 GLUD1 CLTC OSBPL1A UTRN IMMT DYNC1H1 SEMA4D ACTR8 TCOF1 KALRN SYNE1 ENC1 HECTD4 PAICS ARHGAP5 CTR9 ATRNL1 SEC23IP LRP4 | 2.05e-10 | 1285 | 234 | 32 | 35914814 | |
| Pubmed | NUP85 ATR TBC1D5 SSR4 DOCK5 PHKA2 DIP2A DST HELZ PZP RAB35 ARHGAP23 POLRMT CHD8 COLGALT1 ZDHHC17 FHIP2A SACM1L ARVCF CTR9 GALNT6 | 3.97e-09 | 650 | 234 | 21 | 38777146 | |
| Pubmed | SSR4 AKR1C2 PI4KA CLTC DCAF17 PLD1 CAMTA1 UTRN WWP1 DOCK9 ICA1 ENC1 ZNF254 COLGALT1 ZDHHC17 LDLR PAICS ARHGAP5 CTR9 ATRNL1 TRAPPC10 HINT3 KIAA0040 FUCA2 TANGO2 NLRP4 STAG2 | 5.97e-09 | 1084 | 234 | 27 | 11544199 | |
| Pubmed | EML6 CHD4 URB2 MYSM1 FAT1 DST SVIL AMOTL1 CLTC PEX19 DYNC1H1 PLD4 CHD8 LDLR MYOF | 9.25e-09 | 332 | 234 | 15 | 37433992 | |
| Pubmed | GAPDH CHD4 ACTN2 SSR4 DYSF NEK9 AKR1C2 DST PIK3C2A AGL CLTC UTRN KALRN SYNE1 WWP1 DOCK9 INTS4 STAG2 | 9.43e-09 | 497 | 234 | 18 | 23414517 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GBF1 ATR GAPDH CHD4 SSBP1 URB2 SSR4 TRIP13 NEK9 RPTOR PI4KA GLUD1 CLTC IMMT DYNC1H1 SEC23A GPI TCOF1 SYNE1 POLRMT GLOD4 COLGALT1 PAICS SACM1L TGM3 RIC8B CTR9 RRP9 SEC23IP RPL13A STAG2 | 9.78e-09 | 1425 | 234 | 31 | 30948266 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 NUP85 KIAA0319L PANX1 DYSF DIP2A FAT1 DST PTPRS RPTOR PI4KA DYNC1H1 TRAF7 KALRN WWP1 DOCK9 RTTN HECTD4 POLRMT CHD8 LDLR MYOF ARVCF KLHL36 LRP4 LRP5 | 3.64e-08 | 1105 | 234 | 26 | 35748872 |
| Pubmed | CHD4 URB2 DST CLTC HELZ ASCC3 UTRN IMMT DYNC1H1 SEC23A TCOF1 USP24 POLRMT CHD8 PAICS TGM3 RRP9 STAG2 ZMYM3 | 1.15e-07 | 653 | 234 | 19 | 22586326 | |
| Pubmed | URB2 MAP3K4 CLTC HERC3 CAMTA1 DYNC1H1 SYNE1 DOCK9 DLGAP4 ZDHHC17 FHIP2A SACM1L TENM3 ACOT11 ZMYM3 | 1.34e-07 | 407 | 234 | 15 | 12693553 | |
| Pubmed | 3.17e-07 | 22 | 234 | 5 | 35120648 | ||
| Pubmed | GBF1 TRIP13 NEK9 FREM1 PIK3C2A RPTOR AGL CLTC DCAF17 UTRN IMMT TECPR1 POLRMT TGM3 PRKAG1 | 3.31e-07 | 437 | 234 | 15 | 20562859 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NUP85 GAPDH CHD4 URB2 TRIP13 F5 DST PI4KA SVIL GLUD1 CLTC ASCC3 UTRN IMMT DYNC1H1 SEC23A GPI RAB35 TCOF1 SYNE1 RRP9 RPL13A STAG2 | 5.24e-07 | 1024 | 234 | 23 | 24711643 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GBF1 GAPDH TBC1D5 CHD4 SSBP1 NLN PIK3C2A AGL A2ML1 GLUD1 CLTC UTRN IMMT SEC23A GPI RAB35 TCOF1 LAMP2 GLOD4 TBL1XR1 PAICS SACM1L MYOF TGM3 PRKAG1 NUDCD1 RPL13A | 6.34e-07 | 1367 | 234 | 27 | 32687490 |
| Pubmed | GAPDH FSTL4 CHD4 SSBP1 SSR4 RPTOR AGL CLTC OSBPL1A IMMT DYNC1H1 HSP90AA4P RAB35 SLF1 TCOF1 DOCK9 POLRMT CHD8 PAICS TGM3 CTR9 RRP9 POLQ RPL13A | 1.12e-06 | 1153 | 234 | 24 | 29845934 | |
| Pubmed | 1.20e-06 | 4 | 234 | 3 | 1838307 | ||
| Pubmed | Antigen presentation by CD1 and MHC-encoded class I-like molecules. | 1.20e-06 | 4 | 234 | 3 | 8729450 | |
| Pubmed | 1.20e-06 | 4 | 234 | 3 | 12415264 | ||
| Pubmed | Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. | 1.20e-06 | 4 | 234 | 3 | 24556395 | |
| Pubmed | GBF1 NUP85 GAPDH PANX1 CHD4 F5 PIK3C2A PI4KA CLTC HELZ PLD1 ASCC3 IMMT DYNC1H1 GPI DOCK9 COLGALT1 LDLR PAICS FHOD1 PRKAG1 RPL13A IL2RG STAG2 | 1.41e-06 | 1168 | 234 | 24 | 19946888 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATR GAPDH KIAA0319L FSTL4 SSR4 NEK9 FAT1 PTPRS SVIL DNASE1L1 TRAF7 NPR3 FOLR1 LAMP2 COLGALT1 LDLR PAICS SACM1L MYOF TENM3 FHOD1 LRP4 LRP5 FUCA2 | 2.27e-06 | 1201 | 234 | 24 | 35696571 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MIS18BP1 GBF1 NUP85 GAPDH TBC1D5 CHD4 URB2 SSR4 RPTOR CLTC MCAT IL17RA RMND1 GPI ELOA RAB35 TCOF1 CHD8 LAMP2 LDLR SACM1L FHOD1 MTX1 ZMYM3 | 2.34e-06 | 1203 | 234 | 24 | 29180619 |
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 10488738 | ||
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 23677998 | ||
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 3097645 | ||
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 15032598 | ||
| Pubmed | Genomic organization and chromosomal localization of the mouse synexin gene. | 2.98e-06 | 5 | 234 | 3 | 8053909 | |
| Pubmed | 2.98e-06 | 5 | 234 | 3 | 18337560 | ||
| Pubmed | A physical map linking the five CD1 human thymocyte differentiation antigen genes. | 2.98e-06 | 5 | 234 | 3 | 2583117 | |
| Pubmed | CD1 genotyping of patients with Mycobacterium malmoense pulmonary disease. | 2.98e-06 | 5 | 234 | 3 | 11580851 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | GAPDH ACTN2 DYSF PROM1 PTPRD PTPRS GSTA5 CLTC C5 PZP DYNC1H1 CNTN1 GPI NPR3 FOLR1 WWP1 SI LAMP2 GLOD4 PAICS MYOF FUCA2 | 3.91e-06 | 1070 | 234 | 22 | 23533145 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NUP85 GAPDH SSBP1 SSR4 F5 DST KLHL7 SVIL AMOTL1 GLUD1 CLTC ASCC3 IMMT DYNC1H1 ELOA NMNAT1 POLRMT PAICS MYOF TGM3 RRP9 FHOD1 STON2 RPL13A | 4.92e-06 | 1257 | 234 | 24 | 36526897 |
| Pubmed | GAPDH TRPM7 KIAA0319L CHD4 DOCK5 FAT1 DST PI4KA AMOTL1 CLTC PLD1 DYNC1H1 SEC23A GPI TCOF1 MUC16 TENM3 SEC23IP | 6.25e-06 | 777 | 234 | 18 | 35844135 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NUP85 SARM1 URB2 SSR4 TRIP13 RPTOR PI4KA CLTC ASCC3 IMMT DYNC1H1 SEC23A TCOF1 USP24 ZDHHC17 SACM1L SEC23IP MTX1 STAG2 ZMYM3 | 6.87e-06 | 942 | 234 | 20 | 31073040 |
| Pubmed | 7.17e-06 | 40 | 234 | 5 | 25275127 | ||
| Pubmed | GBF1 NUP85 CHD4 TRIP13 NEK9 CLTC ASCC3 IMMT DYNC1H1 SEC23A USP24 PAICS PPP4R3A CTR9 SEC23IP STAG2 | 7.83e-06 | 638 | 234 | 16 | 33239621 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 TRPM7 TBC1D5 KIAA0319L PANX1 DOCK5 PROM1 FAT1 GSTA5 PI4KA MPZ WWP1 DOCK9 ARVCF STON2 | 8.41e-06 | 569 | 234 | 15 | 30639242 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 MYO9A TBC1D5 NCAM2 TRIP13 NEK9 DOCK5 ODF2L PTPRS RPTOR KCNMA1 CAMTA1 UTRN CUL4A CYP4V2 SEMA4D WWP1 ENC1 HECTD4 TBL1XR1 RIC8B PRKAG1 STYXL1 LRP5 TANGO2 STAG2 | 9.48e-06 | 1489 | 234 | 26 | 28611215 |
| Pubmed | GAPDH TLR6 DST AGL CNTN5 CUL4A TCOF1 LDHAL6B TLR10 PRKAG1 FUCA2 | 1.01e-05 | 313 | 234 | 11 | 20800603 | |
| Pubmed | 1.03e-05 | 7 | 234 | 3 | 7595098 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.09e-05 | 21 | 234 | 4 | 21337463 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GBF1 ATR SARM1 SSBP1 NEK9 ELOVL7 DOCK5 NLN FAT1 PTPRS C5 RMND1 GPI WWP1 DLGAP4 CHD8 LDLR MYOF SEC23IP INTS4 MTX1 | 1.16e-05 | 1061 | 234 | 21 | 33845483 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GAPDH CHD4 SSBP1 SSR4 TRIP13 NEK9 AGL GLUD1 CLTC IMMT DYNC1H1 SEC23A CUL4A GPI TCOF1 USP24 GLOD4 COLGALT1 LDLR PAICS CTR9 FHOD1 PRKAG1 RPL13A STAG2 | 1.17e-05 | 1415 | 234 | 25 | 28515276 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GBF1 GAPDH CHD4 SSBP1 TRIP13 NEK9 PHKA2 DST AGL SVIL AMOTL1 GLUD1 CLTC PEX19 ASCC3 DYNC1H1 SEC23A GPI TCOF1 XRCC4 PAICS RPL13A | 1.19e-05 | 1149 | 234 | 22 | 35446349 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.28e-05 | 208 | 234 | 9 | 33230847 | |
| Pubmed | 1.51e-05 | 162 | 234 | 8 | 25826454 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.54e-05 | 268 | 234 | 10 | 33024031 | |
| Pubmed | PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. | 1.91e-05 | 24 | 234 | 4 | 24710276 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 1.91e-05 | 24 | 234 | 4 | 30190310 | |
| Pubmed | 1.98e-05 | 49 | 234 | 5 | 21362503 | ||
| Pubmed | ATR GAPDH SSBP1 SSR4 NEK9 CHUK FAT1 DST SVIL CLTC IMMT PRKAG1 | 2.00e-05 | 401 | 234 | 12 | 25852190 | |
| Pubmed | GBF1 GAPDH CHD4 SSBP1 SSR4 AKR1C2 PIK3C2A AGL SVIL CLTC MCAT C5 PLD1 ASCC3 DYNC1H1 SEC23A GPI ELOA NMNAT1 TCOF1 LAMP2 ARHGAP5 STON2 KLHL12 | 2.05e-05 | 1371 | 234 | 24 | 36244648 | |
| Pubmed | GAPDH ACTN2 GLUD1 GLUD2 CLTC IMMT DYNC1H1 CNTN1 GPI DLGAP4 GRIN1 MAPRE3 | 2.10e-05 | 403 | 234 | 12 | 30562941 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 ATR CHD4 RPTOR SVIL CLTC HELZ ELOA TCOF1 USP24 PPP4R3A MYOF CTR9 FHOD1 TRAPPC10 STAG2 ZMYM3 | 2.24e-05 | 774 | 234 | 17 | 15302935 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 F5 PI4KA A2ML1 KCNMA1 PZP IMMT ARHGAP23 KALRN USP24 CHD8 TBL1XR1 ARHGAP5 | 2.30e-05 | 475 | 234 | 13 | 31040226 |
| Pubmed | 2.39e-05 | 225 | 234 | 9 | 12168954 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CHD4 GLUD1 GLUD2 CLTC DYNC1H1 SEC23A TECPR1 PLD4 GPI USP24 MYOF | 2.42e-05 | 344 | 234 | 11 | 30333137 |
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 2.45e-05 | 9 | 234 | 3 | 7544347 | |
| Pubmed | 2.45e-05 | 9 | 234 | 3 | 2293612 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.47e-05 | 226 | 234 | 9 | 37839992 | |
| Pubmed | 2.53e-05 | 284 | 234 | 10 | 29459677 | ||
| Pubmed | 2.84e-05 | 230 | 234 | 9 | 35449600 | ||
| Pubmed | TBC1D5 SSR4 PTPRD PTPRS PI4KA SVIL CLTC PEX19 KCNMA1 HELZ UTRN ELOA COLGALT1 PPP4R3A ARHGAP5 ARVCF CTR9 INTS4 STYXL1 PHLPP2 | 3.20e-05 | 1049 | 234 | 20 | 27880917 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 3.35e-05 | 235 | 234 | 9 | 28378594 | |
| Pubmed | 3.48e-05 | 10 | 234 | 3 | 20227302 | ||
| Pubmed | [Expression of toll-like receptors in human epidermal keratinocytes]. | 3.48e-05 | 10 | 234 | 3 | 18686608 | |
| Pubmed | 3.48e-05 | 10 | 234 | 3 | 11782555 | ||
| Pubmed | A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. | 3.48e-05 | 10 | 234 | 3 | 18548008 | |
| Pubmed | A family of human receptors structurally related to Drosophila Toll. | 3.48e-05 | 10 | 234 | 3 | 9435236 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GBF1 NUP85 PTPRD PTPRS AGL GLUD1 PEX19 HELZ RMND1 ASCC3 UTRN IMMT HSP90AA4P TCOF1 POLRMT PAICS PPP4R3A CTR9 STYXL1 | 3.73e-05 | 974 | 234 | 19 | 28675297 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GAPDH SPTA1 CHD4 AKR1C2 DST CLTC UTRN IMMT DYNC1H1 SEC23A GPI SYNE1 CHD8 PAICS MYOF RPL13A DISP1 | 3.77e-05 | 807 | 234 | 17 | 30575818 |
| Pubmed | MAGI1 GAPDH CHD4 SSR4 TRIP13 PIK3C2A SVIL GLUD1 CLTC ASCC3 IMMT DYNC1H1 CUL4A GPI TCOF1 WWP1 TBL1XR1 SACM1L MYOF ARVCF TRAPPC10 RPL13A | 4.10e-05 | 1247 | 234 | 22 | 27684187 | |
| Pubmed | 4.16e-05 | 57 | 234 | 5 | 38223760 | ||
| Pubmed | 4.49e-05 | 304 | 234 | 10 | 32235678 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 31421907 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 28621566 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 32778134 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 32078638 | ||
| Pubmed | Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1. | 4.51e-05 | 2 | 234 | 2 | 28430577 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 28911206 | ||
| Pubmed | Molecular basis of human glutamate dehydrogenase regulation under changing energy demands. | 4.51e-05 | 2 | 234 | 2 | 15578726 | |
| Pubmed | Induction of excitatory and inhibitory presynaptic differentiation by GluD1. | 4.51e-05 | 2 | 234 | 2 | 22138648 | |
| Pubmed | MAGI-1 interacts with Slo1 channel proteins and suppresses Slo1 expression on the cell surface. | 4.51e-05 | 2 | 234 | 2 | 19403801 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 2578455 | ||
| Pubmed | Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. | 4.51e-05 | 2 | 234 | 2 | 19660432 | |
| Pubmed | Potentiation of neuronal activity by tonic GluD1 current in brain slices. | 4.51e-05 | 2 | 234 | 2 | 37154294 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 31898404 | ||
| Pubmed | Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux. | 4.51e-05 | 2 | 234 | 2 | 15378063 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 34648034 | ||
| Pubmed | Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate. | 4.51e-05 | 2 | 234 | 2 | 20529287 | |
| Pubmed | Quantitative and electron microscopic studies of sensory ganglion cells of the Sprawling mouse. | 4.51e-05 | 2 | 234 | 2 | 894335 | |
| Pubmed | Unexpected histone H3 tail-clipping activity of glutamate dehydrogenase. | 4.51e-05 | 2 | 234 | 2 | 23673664 | |
| Pubmed | Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer. | 4.51e-05 | 2 | 234 | 2 | 29649003 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 25056943 | ||
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 24442550 | ||
| Pubmed | The Amplifying Pathway of the β-Cell Contributes to Diet-induced Obesity. | 4.51e-05 | 2 | 234 | 2 | 27137930 | |
| Pubmed | GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate Distribution. | 4.51e-05 | 2 | 234 | 2 | 26440896 | |
| Pubmed | 4.51e-05 | 2 | 234 | 2 | 12742085 | ||
| Interaction | RAC2 interactions | TRPM7 TBC1D5 KIAA0319L PANX1 DOCK5 FAT1 DST PIK3C2A PI4KA GLUD2 CLTC PLD1 UTRN IMMT TRAF7 RAB35 DOCK9 MYOF TENM3 FHOD1 SEC23IP STON2 LRP5 SLC16A7 | 8.82e-07 | 674 | 230 | 24 | int:RAC2 |
| Interaction | RAC1 interactions | MAGI1 GBF1 TRPM7 TBC1D5 PANX1 MAP3K4 DOCK5 FAT1 DST PTPRS PI4KA CLTC PLD1 UTRN IMMT TRAF7 RAB35 ARHGAP23 KALRN DOCK9 DLGAP4 GRIN1 ARHGAP5 MYOF FHOD1 STON2 PRKAG1 LRP4 LRP5 SLC16A7 | 4.46e-06 | 1063 | 230 | 30 | int:RAC1 |
| Interaction | RHOJ interactions | TRPM7 TBC1D5 PANX1 DIP2A FAT1 PTPRS PI4KA CLTC UTRN IMMT RAB35 DOCK9 USP24 POLRMT ARHGAP5 MYOF FHOD1 STON2 LRP5 RPL13A SLC16A7 | 1.29e-05 | 633 | 230 | 21 | int:RHOJ |
| Cytoband | 1q22-q23 | 3.65e-05 | 13 | 235 | 3 | 1q22-q23 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | TLR6 TLR8 PROM1 CD101 IL17RA SEMA4D LAIR1 LAMP2 TLR10 CD1A CD1B CD1D IL2RG CD96 | 7.18e-06 | 394 | 154 | 14 | 471 |
| GeneFamily | Fibronectin type III domain containing | 9.42e-06 | 160 | 154 | 9 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.90e-06 | 161 | 154 | 9 | 593 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.90e-05 | 9 | 154 | 3 | 1234 | |
| GeneFamily | CD molecules|Toll like receptors | 6.96e-05 | 10 | 154 | 3 | 948 | |
| GeneFamily | Low density lipoprotein receptors | 1.63e-04 | 13 | 154 | 3 | 634 | |
| GeneFamily | Immunoglobulin like domain containing | 2.52e-04 | 193 | 154 | 8 | 594 | |
| GeneFamily | Kelch like|BTB domain containing | 4.40e-04 | 42 | 154 | 4 | 617 | |
| GeneFamily | Potassium calcium-activated channels | 1.06e-03 | 6 | 154 | 2 | 255 | |
| GeneFamily | Ferlin family | 1.06e-03 | 6 | 154 | 2 | 828 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.07e-03 | 53 | 154 | 4 | 532 | |
| GeneFamily | Cohesin complex | 1.95e-03 | 8 | 154 | 2 | 1060 | |
| GeneFamily | Anoctamins | 3.10e-03 | 10 | 154 | 2 | 865 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 4.50e-03 | 12 | 154 | 2 | 670 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.10e-03 | 41 | 154 | 3 | 1298 | |
| GeneFamily | C1-set domain containing | 5.46e-03 | 42 | 154 | 3 | 591 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MIS18BP1 ATR GAPDH NEK9 MYSM1 DIP2A CD101 HELZ IL17RA ASCC3 UTRN DYNC1H1 SEMA4D SLF1 SYNE1 DOCK9 HECTD4 USP24 LAIR1 CST7 FHIP2A TBL1XR1 PPP4R3A SACM1L FHOD1 TRAPPC10 KIAA0040 RPL13A IL2RG SLC16A7 STAG2 CD96 FCMR | 1.29e-06 | 1492 | 233 | 33 | M40023 |
| Coexpression | FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP | 2.82e-06 | 45 | 233 | 6 | M40886 | |
| Coexpression | FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP | 1.15e-05 | 57 | 233 | 6 | M40884 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_DN | PANX1 GLUD1 CLTC IL17RA DYNC1H1 SEC14L1 SEMA4D SYNE1 LAIR1 MYOF | 1.25e-05 | 199 | 233 | 10 | M7036 |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | TBC1D5 CYP4V2 SYNE1 ENC1 CHD8 CST7 NPEPL1 ARHGAP5 TRAPPC10 CD96 | 1.25e-05 | 199 | 233 | 10 | M4331 |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | TRIP13 CHUK IMMT DYNC1H1 SEC23A SEMA4D ENC1 GLOD4 HINT3 SLC16A7 | 1.31e-05 | 200 | 233 | 10 | M7744 |
| Coexpression | FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP | 1.55e-05 | 60 | 233 | 6 | M40883 | |
| Coexpression | TRAYNOR_RETT_SYNDROM_UP | 2.71e-05 | 40 | 233 | 5 | M2712 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 ATR STAG1 MAP3K4 FAT1 DST PIK3C2A HELZ ASCC3 SEC14L1 WWP1 DOCK9 ENC1 USP24 ZDHHC17 XRCC4 LDLR MYOF SLC16A7 STAG2 PHLPP2 | 2.89e-05 | 856 | 233 | 21 | M4500 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 6.88e-05 | 196 | 233 | 9 | M9243 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | DCHS2 RELN AKR1C2 DOCK5 PTPRS OSBPL1A KCNN3 PLD1 SLC25A23 SEMA4D SYNE1 ZDHHC17 STON2 | 6.99e-05 | 402 | 233 | 13 | M45754 |
| Coexpression | GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP | 8.04e-05 | 200 | 233 | 9 | M7235 | |
| Coexpression | GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP | 8.04e-05 | 200 | 233 | 9 | M8722 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 8.04e-05 | 200 | 233 | 9 | M7978 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_HP_UP | 8.13e-05 | 50 | 233 | 5 | M13746 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | ATR TBC1D5 TLR6 F5 TLR8 CHUK PIK3C2A WWP1 ENC1 HECTD4 LAIR1 XRCC4 PRKAG1 TRAPPC10 | 1.03e-04 | 477 | 233 | 14 | M40930 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN HECW1 ABCA13 SPTA1 NCAM2 ANO5 FREM1 FAT1 PTPRD CNTN1 KALRN LOXHD1 GUCY2F | 1.72e-11 | 184 | 232 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN HECW1 ABCA13 SPTA1 NCAM2 ANO5 FREM1 FAT1 PTPRD CNTN1 KALRN LOXHD1 GUCY2F | 1.72e-11 | 184 | 232 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN HECW1 ABCA13 SPTA1 NCAM2 ANO5 FREM1 FAT1 PTPRD CNTN1 KALRN LOXHD1 GUCY2F | 1.72e-11 | 184 | 232 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | SYTL2 DIP2A ODF2L DCAF17 MUC16 CST7 ZDHHC17 SACM1L RPL13A IL2RG CD96 FCMR | 3.61e-10 | 189 | 232 | 12 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | SPTA1 SSR4 NDUFC1 PROM1 KCNN3 NPR3 SYNE1 CRYGD STON2 POLQ MYB | 4.68e-09 | 188 | 232 | 11 | 557a0ac069a6ff4e687cac032f64170b9b247165 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-08 | 162 | 232 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-08 | 176 | 232 | 10 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | MIS18BP1 GAPDH SYTL2 KIAA0319L MAP3K4 ODF2L IL4I1 GPR34 IL2RG CD96 | 7.14e-08 | 192 | 232 | 10 | 12f7ea575da5d650c740e6060f5dab0478e563dd |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ATR MBTPS2 PIK3C2A CLTC UTRN DYNC1H1 ACTR8 CTR9 TRAPPC10 STAG2 | 7.49e-08 | 193 | 232 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.87e-08 | 194 | 232 | 10 | 64535db0420e53e4d777d2333b5051e63e8a3373 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAGI1 RELN DYSF KCNN3 OSBP2 TSPAN11 KALRN PKD1L3 LOXHD1 STON2 | 9.52e-08 | 198 | 232 | 10 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MAGI1 RELN DYSF KCNN3 OSBP2 TSPAN11 KALRN PKD1L3 LOXHD1 STON2 | 9.52e-08 | 198 | 232 | 10 | b3a020522e064bb61949d38e442f24026e339364 |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Lymphatic|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | RELN OXGR1 DYSF DOCK5 KCNN3 OSBP2 TSPAN11 ARHGAP23 KALRN STON2 | 1.05e-07 | 200 | 232 | 10 | e65d4ae3d48f68c12edd5dc2c2f4e25e4acfadf1 |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Lymphatic|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | RELN OXGR1 DYSF DOCK5 KCNN3 OSBP2 TSPAN11 ARHGAP23 KALRN STON2 | 1.05e-07 | 200 | 232 | 10 | 4ec8e30dd241d83a1bba1c5967b6a4656afbfafd |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Lymphatic-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | RELN OXGR1 DYSF DOCK5 KCNN3 OSBP2 TSPAN11 ARHGAP23 KALRN STON2 | 1.05e-07 | 200 | 232 | 10 | f99d0d3f51b4893fa7898c5b435494358a654cbd |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.05e-07 | 200 | 232 | 10 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-07 | 177 | 232 | 9 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 4.18e-07 | 178 | 232 | 9 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-07 | 183 | 232 | 9 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 5.52e-07 | 184 | 232 | 9 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.04e-07 | 186 | 232 | 9 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-07 | 188 | 232 | 9 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-07 | 188 | 232 | 9 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-07 | 188 | 232 | 9 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-07 | 189 | 232 | 9 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-07 | 190 | 232 | 9 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-07 | 190 | 232 | 9 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.54e-07 | 191 | 232 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 7.54e-07 | 191 | 232 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.87e-07 | 192 | 232 | 9 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | ILEUM-inflamed-(1)_Th17_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.22e-07 | 193 | 232 | 9 | 0663c57e1b8b8dd70d617d029fc7bdbbda8c1208 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.22e-07 | 193 | 232 | 9 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.58e-07 | 194 | 232 | 9 | b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 8.96e-07 | 195 | 232 | 9 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 198 | 232 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 198 | 232 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 199 | 232 | 9 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 232 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 232 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 199 | 232 | 9 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-06 | 199 | 232 | 9 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 168 | 232 | 8 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | Dendritic_Cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.92e-06 | 175 | 232 | 8 | 584290a51f9975782a5ac8c6ad67c778d8323f8c | |
| ToppCell | Dendritic_Cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.45e-06 | 178 | 232 | 8 | 3a28103cf282cc3637d1875a3b4cd7ddf3207687 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.45e-06 | 178 | 232 | 8 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-06 | 181 | 232 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-06 | 181 | 232 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.24e-06 | 182 | 232 | 8 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | (6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.68e-06 | 184 | 232 | 8 | 03ea613e00b45c81b752c14505a0538d698f551e | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.91e-06 | 185 | 232 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.91e-06 | 185 | 232 | 8 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-06 | 185 | 232 | 8 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 185 | 232 | 8 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.91e-06 | 185 | 232 | 8 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-06 | 185 | 232 | 8 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 5.91e-06 | 185 | 232 | 8 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.15e-06 | 186 | 232 | 8 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.15e-06 | 186 | 232 | 8 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.39e-06 | 187 | 232 | 8 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.65e-06 | 188 | 232 | 8 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-06 | 188 | 232 | 8 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.65e-06 | 188 | 232 | 8 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | VE-CD8-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 6.67e-06 | 134 | 232 | 7 | 4413fec495907184b6d5cf4bda39359506b2c172 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-06 | 189 | 232 | 8 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-06 | 189 | 232 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.91e-06 | 189 | 232 | 8 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.91e-06 | 189 | 232 | 8 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-06 | 190 | 232 | 8 | 32400c62cb9de4c2b24af4206c21a0215ab12212 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.18e-06 | 190 | 232 | 8 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-06 | 190 | 232 | 8 | b2bd2cb384bb8a5662064ed1aee68e905e1f780d | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 190 | 232 | 8 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-06 | 190 | 232 | 8 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.18e-06 | 190 | 232 | 8 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.47e-06 | 191 | 232 | 8 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.47e-06 | 191 | 232 | 8 | b9ef6d82b86271b7e0875a399bb9aae84ef5bad3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.47e-06 | 191 | 232 | 8 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-06 | 192 | 232 | 8 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 7.76e-06 | 192 | 232 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.76e-06 | 192 | 232 | 8 | a7ccbea7c90c070d279d7ad3f2b5b7c0e3efd890 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.06e-06 | 193 | 232 | 8 | 523e2541f9f8d22b3c5263839a57cc1ab23d4963 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.06e-06 | 193 | 232 | 8 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 194 | 232 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.69e-06 | 195 | 232 | 8 | 42382653e977714bff453bece26a6cd66ea2cc1f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.69e-06 | 195 | 232 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 8.69e-06 | 195 | 232 | 8 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.69e-06 | 195 | 232 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-06 | 195 | 232 | 8 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.01e-06 | 196 | 232 | 8 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.01e-06 | 196 | 232 | 8 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.01e-06 | 196 | 232 | 8 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.01e-06 | 196 | 232 | 8 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 9.01e-06 | 196 | 232 | 8 | e1a9198bc51e01308f066323c5e089cfaf04b2ca | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-06 | 196 | 232 | 8 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.01e-06 | 196 | 232 | 8 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.01e-06 | 196 | 232 | 8 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.01e-06 | 196 | 232 | 8 | f278b144b8deaee0bf41682081b9fbb0b1e82b19 | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; HL60; HG-U133A | EPOR ATR STAG1 OSBPL1A UTRN DYNC1H1 ACTR8 NPEPL1 RRP9 GALNT6 SLC16A7 | 5.00e-06 | 194 | 231 | 11 | 1369_DN |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; HL60; HT_HG-U133A | 5.79e-06 | 197 | 231 | 11 | 3030_DN | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | TBL1Y SARM1 ACTN2 TLR8 KALRN XRCC4 MYOF ARVCF ACOT11 IL2RG FCMR | 6.07e-06 | 198 | 231 | 11 | 2760_UP |
| Disease | vesicular integral-membrane protein VIP36 measurement | 5.46e-05 | 10 | 231 | 3 | EFO_0022012 | |
| Disease | heel bone mineral density, urate measurement | 9.93e-05 | 182 | 231 | 8 | EFO_0004531, EFO_0009270 | |
| Disease | proliferative diabetic retinopathy | 1.17e-04 | 61 | 231 | 5 | EFO_0009322 | |
| Disease | dihomo-linoleate 20:2n6 measurement | 1.82e-04 | 3 | 231 | 2 | EFO_0021064 | |
| Disease | fascioliasis (biomarker_via_orthology) | 1.82e-04 | 3 | 231 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | sensory system disease (implicated_via_orthology) | 1.82e-04 | 3 | 231 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 2.01e-04 | 15 | 231 | 3 | DOID:13413 (biomarker_via_orthology) | |
| Disease | pathological myopia | 2.46e-04 | 111 | 231 | 6 | EFO_0004207 | |
| Disease | Moyamoya disease | 2.68e-04 | 40 | 231 | 4 | MONDO_0016820 | |
| Disease | pneumonia, COVID-19 | 2.71e-04 | 113 | 231 | 6 | EFO_0003106, MONDO_0100096 | |
| Disease | Polydactyly | 3.27e-04 | 117 | 231 | 6 | C0152427 | |
| Disease | response to non-steroidal anti-inflammatory, drug-induced liver injury | 3.62e-04 | 4 | 231 | 2 | EFO_0004228, EFO_0005533 | |
| Disease | monocyte chemotactic protein-2 measurement | 3.62e-04 | 4 | 231 | 2 | EFO_0010789 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 7.93e-04 | 53 | 231 | 4 | EFO_0001422, EFO_0003095 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 8.97e-04 | 6 | 231 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | sh2 domain-containing protein 1a measurement | 8.97e-04 | 6 | 231 | 2 | EFO_0020737 | |
| Disease | torsin-1A-interacting protein 1 measurement | 8.97e-04 | 6 | 231 | 2 | EFO_0802137 | |
| Disease | gout | 9.33e-04 | 196 | 231 | 7 | EFO_0004274 | |
| Disease | Parkinson disease | 1.02e-03 | 321 | 231 | 9 | MONDO_0005180 | |
| Disease | glycerol measurement | 1.08e-03 | 26 | 231 | 3 | EFO_0010115 | |
| Disease | Glycogen Storage Disease | 1.21e-03 | 27 | 231 | 3 | C0017919 | |
| Disease | LDL cholesterol change measurement | 1.25e-03 | 7 | 231 | 2 | EFO_0007804 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.25e-03 | 7 | 231 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | rho GTPase-activating protein 30 measurement | 1.25e-03 | 7 | 231 | 2 | EFO_0802012 | |
| Disease | Colorectal Carcinoma | GAPDH TRPM7 ABCA13 F5 PROM1 FAT1 PTPRD PTPRS CCDC62 PZP CNTN1 TCOF1 KALRN SYNE1 | 1.37e-03 | 702 | 231 | 14 | C0009402 |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 1.43e-03 | 62 | 231 | 4 | EFO_0803360, EFO_0803362 | |
| Disease | cerebral infarction (is_implicated_in) | 1.49e-03 | 29 | 231 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | D dimer measurement | 1.64e-03 | 30 | 231 | 3 | EFO_0004507 | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 1.66e-03 | 8 | 231 | 2 | EFO_0801556 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 1.66e-03 | 8 | 231 | 2 | EFO_0802066 | |
| Disease | mean reticulocyte volume | ATR SPTA1 CHD4 URB2 DIP2A CNTN5 OSBP2 CUL4A RTTN TBL1XR1 PPP4R3A SEC23IP INTS4 STAG2 MYB | 1.68e-03 | 799 | 231 | 15 | EFO_0010701 |
| Disease | myocardial infarction | 1.86e-03 | 350 | 231 | 9 | EFO_0000612 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.91e-03 | 67 | 231 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | obsolete_red blood cell distribution width | ATR TBC1D5 SPTA1 CHD4 DOCK5 CNTN5 OSBP2 PLD1 RMND1 CUL4A ARHGAP23 KALRN ENC1 HECTD4 TBL1XR1 LOXHD1 PRKAG1 LRP5 KIAA0040 GALNT6 MYB | 2.20e-03 | 1347 | 231 | 21 | EFO_0005192 |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.36e-03 | 71 | 231 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | cerebrospinal fluid clusterin measurement | 2.58e-03 | 35 | 231 | 3 | EFO_0007657 | |
| Disease | velopharyngeal dysfunction | 2.78e-03 | 122 | 231 | 5 | EFO_0009336 | |
| Disease | Intellectual Disability | STAG1 ASCC3 DYNC1H1 FOLR1 SYNE1 RTTN CHD8 GRIN1 FHIP2A STAG2 | 2.91e-03 | 447 | 231 | 10 | C3714756 |
| Disease | loneliness measurement | 2.98e-03 | 124 | 231 | 5 | EFO_0007865 | |
| Disease | central corneal thickness | 3.15e-03 | 309 | 231 | 8 | EFO_0005213 | |
| Disease | endometrial carcinoma, endometriosis | 3.20e-03 | 11 | 231 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 3.20e-03 | 11 | 231 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Astigmatism | 3.53e-03 | 129 | 231 | 5 | HP_0000483 | |
| Disease | attention deficit hyperactivity disorder, conduct disorder | 3.78e-03 | 40 | 231 | 3 | EFO_0003888, EFO_0004216 | |
| Disease | left ventricular ejection fraction measurement | 3.78e-03 | 40 | 231 | 3 | EFO_0008373 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 3.82e-03 | 12 | 231 | 2 | EFO_0008258 | |
| Disease | lip morphology measurement | 3.85e-03 | 189 | 231 | 6 | EFO_0007845 | |
| Disease | Alzheimer's disease (is_marker_for) | 4.28e-03 | 257 | 231 | 7 | DOID:10652 (is_marker_for) | |
| Disease | ximenoylcarnitine (C26:1) measurement | 4.50e-03 | 13 | 231 | 2 | EFO_0800543 | |
| Disease | transmembrane protein 87B measurement | 4.50e-03 | 13 | 231 | 2 | EFO_0802158 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 4.50e-03 | 13 | 231 | 2 | EFO_0802114 | |
| Disease | spleen volume | 4.64e-03 | 43 | 231 | 3 | EFO_0600047 | |
| Disease | Profound Mental Retardation | 4.85e-03 | 139 | 231 | 5 | C0020796 | |
| Disease | Mental deficiency | 4.85e-03 | 139 | 231 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.85e-03 | 139 | 231 | 5 | C0025363 | |
| Disease | Congenital Heart Defects | 4.95e-03 | 44 | 231 | 3 | C0018798 | |
| Disease | unipolar depression, anxiety | 5.22e-03 | 14 | 231 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 5.22e-03 | 14 | 231 | 2 | cv:C2931907 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 5.78e-03 | 145 | 231 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Alzheimer disease, age at onset | 5.86e-03 | 343 | 231 | 8 | EFO_0004847, MONDO_0004975 | |
| Disease | Benign neoplasm of bladder | 5.99e-03 | 15 | 231 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.99e-03 | 15 | 231 | 2 | C0154091 | |
| Disease | hepcidin:transferrin saturation ratio | 5.99e-03 | 15 | 231 | 2 | EFO_0007902 | |
| Disease | semaphorin-3A measurement | 5.99e-03 | 15 | 231 | 2 | EFO_0008278 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.99e-03 | 15 | 231 | 2 | C0496930 | |
| Disease | Degenerative polyarthritis | 6.20e-03 | 93 | 231 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 6.20e-03 | 93 | 231 | 4 | C0086743 | |
| Disease | Colorectal Neoplasms | 6.39e-03 | 277 | 231 | 7 | C0009404 | |
| Disease | vision disorder | 6.81e-03 | 16 | 231 | 2 | MONDO_0021084 | |
| Disease | Inherited oocyte maturation defect | 6.81e-03 | 16 | 231 | 2 | cv:CN238505 | |
| Disease | neutrophil collagenase measurement | 6.81e-03 | 16 | 231 | 2 | EFO_0008248 | |
| Disease | mean platelet volume | TBC1D5 SPTA1 EML6 ELOVL7 DOCK5 PI4KA CCDC62 SVIL CAMTA1 CUL4A KALRN RTTN CTR9 INTS4 STYXL1 MYB | 6.83e-03 | 1020 | 231 | 16 | EFO_0004584 |
| Disease | platelet component distribution width | TBC1D5 SPTA1 DOCK5 CNTN5 SVIL CAMTA1 CUL4A KALRN SYNE1 DOCK9 RTTN ARVCF MYB | 6.85e-03 | 755 | 231 | 13 | EFO_0007984 |
| Disease | diffuse plaque measurement | DCHS2 MINAR2 RELN ABCA13 FSTL4 NCAM2 AKR1C2 PTPRD CNTN5 HSP90AA4P PDE11A SEMA4D MYB | 7.07e-03 | 758 | 231 | 13 | EFO_0010699 |
| Disease | cognitive inhibition measurement | 7.08e-03 | 50 | 231 | 3 | EFO_0007969 | |
| Disease | Glycogen storage disease | 7.68e-03 | 17 | 231 | 2 | cv:C0017919 | |
| Disease | muscular dystrophy (is_implicated_in) | 7.68e-03 | 17 | 231 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | response to radiation, Urinary retention | 7.68e-03 | 17 | 231 | 2 | GO_0009314, HP_0000016 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 7.68e-03 | 17 | 231 | 2 | cv:C0270914 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 7.72e-03 | 99 | 231 | 4 | DOID:11446 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVSDSVLLLSYTWAQ | 601 | Q14146 | |
| YSLILQNHTSEIFKW | 91 | Q96M60 | |
| DYKSSLIALTAHNWL | 116 | Q5H9S7 | |
| EHKIETWREVYLQDS | 111 | P54619 | |
| QSTFDIHKADWIRKY | 1541 | Q9HCK8 | |
| AAYLITFEKHEEWLT | 81 | Q9Y6Y1 | |
| STHETWAYGKEQILL | 411 | P35609 | |
| TNSEKLYSRWEQDHD | 646 | Q75V66 | |
| AASHVLQTVWSYKEL | 821 | O00192 | |
| DAVKLHLWTNYTTRA | 526 | Q5SY80 | |
| DTAHNVIDYIDTIWK | 316 | Q8N4J0 | |
| SDEKQWHDVSVYLGL | 456 | Q6P9F0 | |
| IWTHEDKIELYSNIE | 251 | Q9H2U9 | |
| ADIEVIWSHAIQKYL | 206 | Q9H981 | |
| AWHKDARIVYIISSQ | 121 | Q8NHS2 | |
| WAETLTKALAHVEAY | 191 | Q969Y2 | |
| VSSCYWKEIVHKTNE | 296 | Q9UPC5 | |
| LAKSHEYQLESWADS | 826 | A8K2U0 | |
| SEAKNYLVHAVSWLR | 336 | Q86UQ4 | |
| EWDKHYRSVELVQQV | 451 | Q8WXI4 | |
| KWEQKYLEESTIRHF | 686 | Q8IY63 | |
| SWLQEVYLTDEVSHV | 176 | Q6P656 | |
| YSTSELKEDQWLQTI | 1561 | Q96PN6 | |
| VKHSSLEGQDIILYW | 281 | P29016 | |
| HQFYKEVDSWISSEL | 941 | Q96F81 | |
| ELYHLKANSWQLVET | 901 | Q9Y2H0 | |
| HWSRAALVYSDDKLE | 196 | P17342 | |
| IHDASLDVTFYWTLK | 596 | O94779 | |
| IEDSYLKHTEIDNQW | 46 | O14807 | |
| YIFIDEAHITQSLTW | 1061 | P20742 | |
| ETISASNAWKSHYEK | 276 | Q9ULJ1 | |
| TSAESFVNVKRWLHE | 91 | Q15286 | |
| RLITQVYLSHTAWTE | 891 | Q96HW7 | |
| NKLSWADIHLVELFY | 151 | Q7RTV2 | |
| EDIKSLTAHVIENYW | 611 | Q6IN85 | |
| LTAHVIENYWKALED | 616 | Q6IN85 | |
| YSSIDHESSTWIIKE | 326 | Q96RS6 | |
| SKIYVSLAHVLTRWE | 561 | Q6IWH7 | |
| HTLKQTLSCYSEVWV | 116 | O76096 | |
| LDHETTKWYQFSILA | 2766 | Q14517 | |
| EQLYWELSQLTHGIK | 12941 | Q8WXI7 | |
| YWELSQLTHSITELG | 13256 | Q8WXI7 | |
| QLYWELSQLTHSITE | 13566 | Q8WXI7 | |
| FTLWNESTHYQILLT | 221 | Q96F46 | |
| IDYVLETAHLLQIWT | 116 | Q8N4N3 | |
| YTKLEENAWNRSHSE | 176 | Q3ZCV2 | |
| VEGKLIDVTNIYWHS | 401 | Q6P0N0 | |
| VYFIDHNTKTTSWLD | 316 | Q96QZ7 | |
| GSIEYLKREWETLHN | 881 | Q12791 | |
| YIWALTQTLRIADHS | 131 | Q9Y4Z2 | |
| HVVVLTRNKEVYSWG | 491 | Q8TD19 | |
| VTLAVSDLQKSLNYW | 156 | Q9HC38 | |
| LTLYSQDELSHLLAW | 386 | P60608 | |
| SQSTDDDKIVQYHWE | 431 | Q8IZA0 | |
| FSQVWYIEIQEKSHS | 5586 | Q03001 | |
| AHYTSLINDETIAVW | 396 | Q15034 | |
| SHRGQIIWKIDASSY | 136 | Q76N89 | |
| IQLRKVWAEAVHYVS | 421 | O15111 | |
| WTITYSLLSHRDNKA | 1076 | Q6ZU64 | |
| NSYWFITADHLIEKL | 166 | Q9NQE9 | |
| KWDESSILAAHRATY | 46 | O14990 | |
| GTETWYESLHAVLKA | 6 | Q9Y6H6 | |
| IWDTILTKHQEGIYN | 11 | Q15053 | |
| SQEVTYAQLDHWALT | 246 | Q6GTX8 | |
| NNHIYWTDVSLKTIS | 686 | O75197 | |
| LEWLAHIFSNDEKSY | 66 | A0A0B4J1V2 | |
| GLNASWYLDHVIVTD | 116 | Q8IVV2 | |
| EAYQTLFLLQHLWSE | 241 | Q5H9U9 | |
| RDYEDLWNVVSHLVK | 391 | Q5H9U9 | |
| KHSSLEGQDIVLYWE | 281 | P06126 | |
| AAANVLRETWLIYKH | 571 | Q9UGI6 | |
| WKNVHKEVTATAYEI | 276 | Q9BYZ2 | |
| EQKELLSNWYHFLVT | 296 | Q9BW27 | |
| SWTIEEYDKHSLHTN | 111 | P59773 | |
| YWLLKDALHDVQFST | 1011 | O00443 | |
| KYHAAVLTNSAEWEA | 381 | Q8NDH3 | |
| WAKQSVALDVLSYHA | 571 | Q9HCR9 | |
| LELKWSHIEWSQTEY | 1736 | Q5H8C1 | |
| ATEIRKWVTTVDKHY | 1206 | O60229 | |
| KWVTTVDKHYRDFSL | 1211 | O60229 | |
| EYILWAASKSQLLAH | 1671 | P42356 | |
| EIQQIFHTTYSEIAW | 46 | O60669 | |
| TILYAKWDSHFRESV | 61 | Q16891 | |
| LSTLEKNDVVQHYWD | 156 | P13473 | |
| SAVSTWHKKADRYIE | 186 | Q8N9W4 | |
| VWYVSNIDGTHIAKT | 181 | P06744 | |
| RLGHILEYNTETDKW | 541 | Q8IXQ5 | |
| WSSKSVTEIHLYFEE | 111 | Q96MN2 | |
| SWTEEEDRIIYQAHK | 146 | P10242 | |
| QSLWEVSESHFKYPI | 181 | Q96RD7 | |
| ELHKLYDEETQNWVS | 2796 | Q9Y4D8 | |
| TITLELLEHNEAYTW | 691 | Q9BXW6 | |
| SAHSQEELAEWQKRY | 201 | P42694 | |
| SYHLKASSEVDRQQW | 251 | Q969R2 | |
| YSLNNGKDWHLVTEE | 1686 | P78509 | |
| LEKWTQYRITTVAHT | 686 | Q13332 | |
| WDSLVYDVEVKSHLL | 136 | Q15645 | |
| SDHAWLRYTVVQLSA | 571 | Q6V1P9 | |
| LTSSDELNTIKWYNL | 186 | Q96P68 | |
| SHLAQDLEKTFQTYW | 251 | Q96BZ4 | |
| WKSYSAVDVLQTLEH | 366 | Q8IVS2 | |
| TEKYPEWLQSHRESL | 196 | P40855 | |
| KVNGEAIYETHTWRS | 361 | Q9BTY2 | |
| YNWALQSSHEVIRAS | 656 | Q13535 | |
| IHSLNVLEGSWVLYE | 121 | P07320 | |
| SKVYWTENVTEHREV | 816 | Q93033 | |
| ILHEYVSSSKWEDAV | 591 | Q9P2H3 | |
| HLSSVEAYNIRTDSW | 486 | Q53G59 | |
| EEALYILWQHNKESL | 481 | Q66K79 | |
| LYDVFLEVSQHWQSK | 161 | P49184 | |
| AYTLLLHAELLQWSD | 1261 | Q9H7D0 | |
| TECIKTYNSDWHLVN | 111 | Q9BZ29 | |
| YNHVLIEETDQLWKV | 621 | Q14241 | |
| LTSRTVHLYDNWIKD | 6 | A1L3X0 | |
| VKHSSLEGQDIVLYW | 281 | P15813 | |
| TVSYFEWLKNLNHVS | 436 | P00367 | |
| HNEAWSTLLRTVYSV | 186 | Q8NCL4 | |
| NETEQTKFWDYLHEI | 471 | Q495W5 | |
| DNYTQDTWRKLHEAV | 56 | Q13619 | |
| LELVASWLNAELYHT | 271 | O75417 | |
| YIDWTDNHKALLVGE | 466 | P01031 | |
| KLSYDKSHDQVWVLS | 546 | Q6MZW2 | |
| YVILDTNLKEWELHS | 406 | P51841 | |
| TNLKEWELHSTYTVD | 411 | P51841 | |
| YIITWDHVVALSNES | 921 | Q12860 | |
| SDVWLNLAHIYVEQK | 681 | Q6PD62 | |
| EYHISSNTWLVPETK | 446 | Q5VV63 | |
| HDTTAAAINWSLYLL | 331 | Q6ZWL3 | |
| NTHLSIYDNLLWECK | 326 | Q9UQ52 | |
| LAWVNDSLHLNYTKI | 21 | Q9UPY8 | |
| SWTEQSVDYRHKFSL | 196 | P31785 | |
| KHSYEDWLENNGLSI | 31 | O43462 | |
| TLDTVRHEALLYTWL | 2571 | Q14204 | |
| SHEELYKWFTSQVIR | 3046 | Q14204 | |
| SEHAQDTYLVLDKWL | 361 | P19235 | |
| SIYSSWAEEQRHLET | 1511 | Q92538 | |
| ENGVSKDVWVYDTLH | 351 | O14682 | |
| HIDWSLDSKYLQTND | 456 | Q6ZMW3 | |
| TINWEDYLAVKHFSV | 121 | Q58FG1 | |
| ESNVSLWLSAVSQYK | 1226 | Q14689 | |
| TVEAINWGLDSYSHK | 331 | Q5W0V3 | |
| GVVAHSDTIQWLYTL | 196 | Q9Y613 | |
| LREWLVAVKSLYHSV | 101 | Q8NBJ5 | |
| ERAATVTKKTYEIWH | 1716 | Q14839 | |
| DLKLWTETIYQSASV | 516 | Q92503 | |
| SHVVWKATDFDVLSY | 86 | Q9NTJ5 | |
| WEASHYLVRQVFKSL | 1026 | O00411 | |
| WDRLTHNDIVATTYL | 466 | O75923 | |
| LSSYWEDISHRIETQ | 661 | O75923 | |
| SWTQLTHAEKVALYR | 71 | Q96KJ9 | |
| KTYHTSLKVAWDLNT | 511 | Q66K64 | |
| TVSYFEWLKNLNHVS | 436 | P49448 | |
| TVLCNEIWTHSYKVS | 186 | P15328 | |
| SHEQKDAWVRDNIYS | 36 | P46019 | |
| QLEKWTEYRITVTAH | 676 | P23468 | |
| YDKNTWTEVHEVKLR | 141 | Q96RQ9 | |
| LATYQTTLLHFWEKT | 231 | Q05084 | |
| VLVHTFWIDTKNYVE | 256 | Q13505 | |
| LEEEWNFTKEITHYI | 726 | Q9Y6R4 | |
| DVLDKELISAFYHTW | 1726 | Q86VV8 | |
| CVELTVWDHYKLTNQ | 861 | Q9HCH5 | |
| VAHISTWLYQAEALL | 1661 | P46939 | |
| QALSSGKHYWEVDTR | 306 | Q8IUD6 | |
| AFISYSEHDSLWVKN | 636 | Q9BXR5 | |
| SEVYVWHGKEVTLAQ | 1601 | O95425 | |
| KALTQWIAEYQEILH | 3826 | Q8NF91 | |
| ETILKHWTRYQSESA | 6791 | Q8NF91 | |
| YVDSKSELVTWTLFH | 41 | A0A494BZU4 | |
| LLDIYTHWQQTSELG | 46 | Q13428 | |
| RWHLASEKGSYEIIQ | 946 | P12259 | |
| NLYTIELTHGEFKWQ | 101 | Q13393 | |
| SIKWTDEYESAIDHN | 201 | Q9NVN3 | |
| IALNDHFVKLISWYD | 301 | P04406 | |
| WSTATDLEKHPYEQR | 131 | Q8WW32 | |
| EHYLQWIEFSISEKV | 751 | O43490 | |
| KFTQDYLWLSIATRH | 881 | Q7Z443 | |
| IALVHWENEELNYIK | 261 | Q9NWS8 | |
| VKWESRDHTTLSDIY | 106 | P0DJJ0 | |
| YINKSETRLGSLHVW | 1761 | P14410 | |
| FEKLVQTVRDYHATW | 276 | Q13017 | |
| LEAEYKKAVTTNQWH | 366 | Q9Y6Y8 | |
| LNISEKQHEVYWKVS | 76 | Q92854 | |
| TTYSKWDNIQELLGH | 346 | Q9BSU1 | |
| DLQAHNKEIYTIKWS | 386 | Q9BZK7 | |
| TYREHTAWVVKASLQ | 1206 | Q8N122 | |
| ILIYHGETIAQWRKS | 656 | Q15436 | |
| TAKYEHAFNSIVWRI | 781 | Q8WXE9 | |
| YNGTLVHEVWKDSAT | 526 | Q08188 | |
| REDIFYTSKLWSNSH | 76 | P52895 | |
| KEDLYLDSLSSHNVW | 1086 | Q9UPV0 | |
| WIKLHADQEYVLQVS | 2071 | Q8N3C0 | |
| LNTVALVTDNAVYHW | 116 | Q00610 | |
| TWAKAYAETTLEHAR | 101 | Q9NQ89 | |
| AHVWNKSVTLYTVKD | 411 | Q9BYT8 | |
| SHATQAIFEILEKSW | 166 | P22234 | |
| ASVTDWVINELRYHL | 891 | Q9NR97 | |
| LWTIKRDIIDYHSLT | 136 | A6PVC2 | |
| IYNLLIQTHVTADEW | 131 | P40200 | |
| TVFLWIYLIKQHNED | 51 | O43677 | |
| VSWLYHNEEVTTISD | 146 | O15394 | |
| ALWEHLSYTEAVNAV | 986 | Q6ZVD8 | |
| VRSKWEYDESHVITA | 36 | Q9Y6J8 | |
| LAHEVGWKYQAVTAT | 141 | P40429 | |
| IKWSHEYQEATIEKI | 681 | Q6SZW1 | |
| LYSTSHDRSVKVWNV | 256 | O43818 | |
| QDVGRYQVSWSLDHK | 81 | P51571 | |
| QSVVDDWIESYKHDR | 96 | Q8N3U4 | |
| DRYKIVETLIQHSDW | 1081 | Q9P227 | |
| EVYQLGDVSQKTTWH | 71 | Q04837 | |
| LQGKVWYREDVSHSN | 216 | Q7Z6L1 | |
| ITHFLQVSWEKTLES | 16 | Q13426 | |
| QKVTLNVHSEYEPSW | 116 | O60667 | |
| SHQEWEYLSLVQKTL | 16 | Q96SK3 | |
| TYENLIHVWDIESKE | 576 | Q6Q0C0 | |
| THWSLLVYLQDKNSF | 101 | Q96LD8 | |
| SHYSILWQLVKITDG | 741 | Q8WVM7 | |
| IHDVKDYITDVNSWL | 2396 | Q9P273 | |
| SWEHIRALATSRYEK | 351 | P02549 | |
| DLQAHSKEIYTIKWS | 396 | Q9BQ87 | |
| SADWQHSTYILLREA | 161 | A1L157 | |
| SEVQHLSQKLYDWSD | 546 | Q9BQI6 | |
| ISYSEHDSAWVKSEL | 646 | Q9Y2C9 | |
| THIDDYSTWDIVKAT | 51 | Q8IUH5 | |
| DLADTLYTKVSEIWH | 231 | Q9H0C1 | |
| TNLYELESRVLTDHW | 126 | Q9UPU5 | |
| VHWSYEETKTFLAIL | 341 | Q63HK3 | |
| SLENVEDVLYFWKHS | 146 | Q9BV35 | |
| ELRAWYSNIKEIHIT | 111 | Q92609 | |
| NIAHTVGLWSYATEK | 381 | P48553 | |
| HLYLVASNTTTWEFI | 201 | Q96GR4 | |
| QVFDILSTYLETHNW | 281 | Q6PF06 | |
| TTLEFQVWSHRTLKA | 76 | Q9H0M0 | |
| NTWSSIYKEDTVLHL | 1656 | Q96QT4 | |
| YLTFVQELNKSLSTW | 1161 | Q14202 | |
| WSSTLTNHRKIYTEE | 221 | O75437 | |
| YSLHWSPREKEVISN | 151 | C9JLR9 | |
| DLSHWETRTYEFTLQ | 261 | Q6ICL3 | |
| HQISVVSEERFYTKW | 666 | P35573 | |
| YWVDSKLHSISSIDV | 576 | P01130 | |
| YLWAAHTSTLADNIK | 206 | Q6P5S2 | |
| QEGKVYWSDSTLHRI | 1091 | O75096 | |
| IHYGSLQSWLRVTEE | 116 | B2RTY4 | |
| YWEDISHRLDAVNTL | 646 | Q9NZM1 | |
| RWKDGSIVIHNLDYS | 106 | P25189 | |
| VLQKDHYLDSSWRTE | 31 | Q5VVJ2 | |
| RVYSWNHIILLVSDD | 156 | Q05586 | |
| FIYESDVLWKHRSNI | 196 | Q9HAN9 |